As we stand on the brink of the personalized medicine era, breakthroughs in areas like genomics are opening up a whole new range of privacy, reliability and security issues. Embedding security and privacy within strategy empowers Life Sciences companies.
This month marks the 16th anniversary of the first full publication of the human genome. Far from being old news, the potential of genomics continues to grow. In what’s already a period of transformation for Life Sciences companies, how can they drive value from genomics, and what are the pitfalls to be avoided?
It’s sink or swim for DPOs as the GDPR creates a tsunami of challenges. With the stakes high, DPOs face great personal risk if they get it wrong. Still, they lack the resources, in-house know-how and authority to pull together the necessary expertise to deal with the rising tide of urgent requests.